Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

August 01, 1999; Volume 56,Issue 2

Articles

  • You have access
    The Soluble Guanylyl Cyclase Inhibitor 1H-[1,2,4]Oxadiazolo[4,3,-a]quinoxalin-1-one Is a Nonselective Heme Protein Inhibitor of Nitric Oxide Synthase and Other Cytochrome P-450 Enzymes Involved in Nitric Oxide Donor Bioactivation
    Martin Feelisch, Peter Kotsonis, Jan Siebe, Bernd Clement and Harald H. H. W. Schmidt
    Molecular Pharmacology August 1999, 56 (2) 243-253; DOI: https://doi.org/10.1124/mol.56.2.243
  • You have access
    Intrastriatal Dopamine Injection Induces Apoptosis Through Oxidation-Involved Activation of Transcription Factors AP-1 and NF-κB in Rats
    Yongquan Luo, Akinori Hattori, James Munoz, Zheng-Hong Qin and George S. Roth
    Molecular Pharmacology August 1999, 56 (2) 254-264; DOI: https://doi.org/10.1124/mol.56.2.254
  • You have access
    Protein Kinase C-Promoted Inhibition of Gα11-Stimulated Phospholipase C-β Activity
    Michelle L. Cunningham, Theresa M. Filtz and T. Kendall Harden
    Molecular Pharmacology August 1999, 56 (2) 265-271; DOI: https://doi.org/10.1124/mol.56.2.265
  • You have access
    Molecular Characterization of Binding of Substrates and Inhibitors to DT-Diaphorase: Combined Approach Involving Site-Directed Mutagenesis, Inhibitor-Binding Analysis, and Computer Modeling
    Shiuan Chen, Kebin Wu, Di Zhang, Mark Sherman, Richard Knox and Chung S. Yang
    Molecular Pharmacology August 1999, 56 (2) 272-278; DOI: https://doi.org/10.1124/mol.56.2.272
  • You have access
    Inducible Cyclic AMP Early Repressor Protein in Rat Pinealocytes: A Highly Sensitive Natural Reporter for Regulated Gene Transcription
    Martina Pfeffer, Erik Maronde, Carlos A. Molina, Horst-Werner Korf and Jörg H. Stehle
    Molecular Pharmacology August 1999, 56 (2) 279-289; DOI: https://doi.org/10.1124/mol.56.2.279
  • You have access
    Photoaffinity Labeling the Torpedo Nicotinic Acetylcholine Receptor with [3H]Tetracaine, a Nondesensitizing Noncompetitive Antagonist
    Richard E. Middleton, Nina P. Strnad and Jonathan B. Cohen
    Molecular Pharmacology August 1999, 56 (2) 290-299; DOI: https://doi.org/10.1124/mol.56.2.290
  • You have access
    Identification of Amino Acids of the Torpedo Nicotinic Acetylcholine Receptor Contributing to the Binding Site for the Noncompetitive Antagonist [3H]Tetracaine
    Martin J. Gallagher and Jonathan B. Cohen
    Molecular Pharmacology August 1999, 56 (2) 300-307; DOI: https://doi.org/10.1124/mol.56.2.300
  • You have access
    A Transmembrane Domain of the Sulfonylurea Receptor Mediates Activation of ATP-Sensitive K+ Channels by K+Channel Openers
    Nathalie D’hahan, Hélène Jacquet, Christophe Moreau, Patrice Catty and Michel Vivaudou
    Molecular Pharmacology August 1999, 56 (2) 308-315; DOI: https://doi.org/10.1124/mol.56.2.308
  • You have access
    Selective Regulation of G Protein-Coupled Receptor-Mediated Signaling by G Protein-Coupled Receptor Kinase 2 in FRTL-5 Cells: Analysis of Thyrotropin, α1B-Adrenergic, and A1 Adenosine Receptor-Mediated Responses
    Luisa Iacovelli, Rossana Franchetti, Deborah Grisolia and Antonio De Blasi
    Molecular Pharmacology August 1999, 56 (2) 316-324; DOI: https://doi.org/10.1124/mol.56.2.316
  • You have access
    Autoregulation of Bradykinin Receptors: Agonists in the Presence of Interleukin-1β Shift the Repertoire of Receptor Subtypes from B2 to B1 in Human Lung Fibroblasts
    Stephen B. Phagoo, Stephen Poole and L. M. Fredrik Leeb-Lundberg
    Molecular Pharmacology August 1999, 56 (2) 325-333; DOI: https://doi.org/10.1124/mol.56.2.325
  • You have access
    Agonistic Effect of Buprenorphine in a Nociceptin/OFQ Receptor-Triggered Reporter Gene Assay
    Stephan Wnendt, Thomas Krüger, Elke Janocha, Dieter Hildebrandt and Werner Englberger
    Molecular Pharmacology August 1999, 56 (2) 334-338; DOI: https://doi.org/10.1124/mol.56.2.334
  • You have access
    Regulation of Nerve Growth Factor Release by Nitric Oxide through Cyclic GMP Pathway in Cortical Glial Cells
    Huabao Xiong, Kiyofumi Yamada, Hussam Jourdi, Meiko Kawamura, Nobuyuki Takei, Daiken Han, Toshitaka Nabeshima and Hiroyuki Nawa
    Molecular Pharmacology August 1999, 56 (2) 339-347; DOI: https://doi.org/10.1124/mol.56.2.339
  • You have access
    Effects of Guanine, Inosine, and Xanthine Nucleotides on β2-Adrenergic Receptor/Gs Interactions: Evidence for Multiple Receptor Conformations
    Roland Seifert, Ulrik Gether, Katharina Wenzel-Seifert and Brian K. Kobilka
    Molecular Pharmacology August 1999, 56 (2) 348-358; DOI: https://doi.org/10.1124/mol.56.2.348
  • You have access
    Selective Killing of Cancer Cells Based on Loss of Heterozygosity and Normal Variation in the Human Genome: A New Paradigm for Anticancer Drug Therapy
    James P. Basilion, Andrea R. Schievella, Erica Burns, Patrice Rioux, Jeffrey C. Olson, Brett P. Monia, Kristina M. Lemonidis, Vincent P. Stanton and David E. Housman
    Molecular Pharmacology August 1999, 56 (2) 359-369; DOI: https://doi.org/10.1124/mol.56.2.359
  • You have access
    Inhibition of Protein Kinases by Balanol: Specificity within the Serine/Threonine Protein Kinase Subfamily
    Juliana Setyawan, Kazunori Koide, Thomas C. Diller, Mark E. Bunnage, Susan S. Taylor, K. C. Nicolaou and Laurence L. Brunton
    Molecular Pharmacology August 1999, 56 (2) 370-376; DOI: https://doi.org/10.1124/mol.56.2.370
  • You have access
    Differential and Selective Inhibition of Protein Kinase A and Protein Kinase C in Intact Cells by Balanol Congeners
    Åsa B. Gustafsson and Laurence L. Brunton
    Molecular Pharmacology August 1999, 56 (2) 377-382; DOI: https://doi.org/10.1124/mol.56.2.377
  • You have access
    Interactions of HIV Protease Inhibitors with ATP-Dependent Drug Export Proteins
    Heike Gutmann, Gert Fricker, Jürgen Drewe, Michael Toeroek and David S. Miller
    Molecular Pharmacology August 1999, 56 (2) 383-389; DOI: https://doi.org/10.1124/mol.56.2.383
  • You have access
    Effect of Loss of DNA Mismatch Repair on Development of Topotecan-, Gemcitabine-, and Paclitaxel-Resistant Variants after Exposure to Cisplatin
    Xinjian Lin and Stephen B. Howell
    Molecular Pharmacology August 1999, 56 (2) 390-395; DOI: https://doi.org/10.1124/mol.56.2.390
  • You have access
    Identification and Characterization of Three New Alternatively Spliced μ-Opioid Receptor Isoforms
    Ying-Xian Pan, Jin Xu, Elizabeth Bolan, Catherine Abbadie, Albert Chang, Amy Zuckerman, Grace Rossi and Gavril W. Pasternak
    Molecular Pharmacology August 1999, 56 (2) 396-403; DOI: https://doi.org/10.1124/mol.56.2.396
  • You have access
    Point Mutations at N434 in D1-S6 of μ1 Na+ Channels Modulate Binding Affinity and Stereoselectivity of Local Anesthetic Enantiomers
    Carla Nau, Sho-Ya Wang, Gary R. Strichartz and Ging Kuo Wang
    Molecular Pharmacology August 1999, 56 (2) 404-413; DOI: https://doi.org/10.1124/mol.56.2.404
  • You have access
    Steric Hindrance Is Not Required for n-Alkanol Cutoff in Soluble Proteins
    Roderic G. Eckenhoff, Jonathan W. Tanner and Jonas S. Johansson
    Molecular Pharmacology August 1999, 56 (2) 414-418; DOI: https://doi.org/10.1124/mol.56.2.414
  • You have access
    Agonist-Induced Phosphorylation by G Protein-Coupled Receptor Kinases of the EP4 Receptor Carboxyl-Terminal Domain in an EP3/EP4 Prostaglandin E2 Receptor Hybrid
    Frank Neuschäfer-Rube, Martin Oppermann, Ulrike Möller, Ulrike Böer and Gerhard P. Püschel
    Molecular Pharmacology August 1999, 56 (2) 419-428; DOI: https://doi.org/10.1124/mol.56.2.419
  • You have access
    Kainate Receptors Coupled to Gi/GoProteins in the Rat Hippocampus
    Rodrigo A. Cunha, João O. Malva and J. A. Ribeiro
    Molecular Pharmacology August 1999, 56 (2) 429-433; DOI: https://doi.org/10.1124/mol.56.2.429
  • You have access
    Dopamine Transporter: Transmembrane Phenylalanine Mutations Can Selectively Influence Dopamine Uptake and Cocaine Analog Recognition
    Zhicheng Lin, Wenfei Wang, Theresa Kopajtic, Randal S. Revay and George R. Uhl
    Molecular Pharmacology August 1999, 56 (2) 434-447; DOI: https://doi.org/10.1124/mol.56.2.434

Accelerated Communication

  • You have access
    The N-Terminal Domain of γ-Aminobutyric AcidBReceptors Is Sufficient to Specify Agonist and Antagonist Binding
    Barbara Malitschek, Claude Schweizer, Miranda Keir, Jakob Heid, Wolfgang Froestl, Johannes Mosbacher, Rainer Kuhn, Jeremy Henley, Cécile Joly, Jean-Phillippe Pin, Klemens Kaupmann and Bernhard Bettler
    Molecular Pharmacology August 1999, 56 (2) 448-454; DOI: https://doi.org/10.1124/mol.56.2.448
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 56 (2)
Molecular Pharmacology
Vol. 56, Issue 2
1 Aug 1999
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Articles
  • Accelerated Communication
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Nelfinavir and PXR
  • Wnt Signaling and Drug Resistance in Cancer
  • Coronavirus in the Brain and the Impact of Smoking
  • Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics